LGVN Stock Analysis: Buy, Sell, or Hold?
LGVN - Longeveron Inc. Common Stock
$6.80
6.10 (866.87%)
▲
5d:
+721.06%
30d:
+1042.86%
90d:
+734.46%
WAIT
LOW Confidence
Analysis Updated: Aug 27, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When LGVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: LGVN is 760.8% above its trading range ($0.79). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: LGVN is 760.8% above its trading range ($0.79). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: LGVN is currently trading at $6.80, which is considered fair relative to its 30-day fair value range of $0.63 to $0.79.
Technical Outlook: Technically, LGVN is showing sideways momentum. Immediate support is located at $0.65, while resistance sits at $7.28. The stock is showing strong short-term momentum, up 866.9% recently.
Market Sentiment: LGVN scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $71.50 (+951.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LGVN is showing sideways momentum. Immediate support is located at $0.65, while resistance sits at $7.28. The stock is showing strong short-term momentum, up 866.9% recently.
Market Sentiment: LGVN scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $71.50 (+951.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.63 -
$0.79
Company Quality Score
27/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+866.9%)
- BULLISH: Trading 951.5% below Wall St target ($71.50)
- WARNING: Composite score 27/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.63 -
$0.79
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.65
Resistance Level
$7.28
Current Trend
Sideways
Technical data as of
Aug 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.45
Wall Street Target
$71.50
(+951.5%)
Revenue Growth (YoY)
-9.2%
Share & Embed Analysis
Last updated: August 27, 2026 9:19 PM ET
Data refreshes hourly during market hours. Next update: 10:19 PM
Data refreshes hourly during market hours. Next update: 10:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LGVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 41 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 70 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 49 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 57 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 45 HOLD |
